These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29533009)

  • 1. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
    Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
    Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy.
    Gao QF; Qiu JC; Huang XH; Xu YM; Li SQ; Sun F; Zhang J; Yang WM; Min QH; Jiang YH; Chen QG; Zhang L; Wang XZ; Ying HQ
    Cancer Cell Int; 2018; 18():153. PubMed ID: 30305803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
    Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
    Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy.
    Ying J; Zhou D; Gu T; Huang J; Liu H
    BMC Cancer; 2019 Mar; 19(1):288. PubMed ID: 30925910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
    Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
    J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Non-Small-Cell Lung Cancer.
    Guo M; Sun T; Zhao Z; Ming L
    Ann Thorac Cardiovasc Surg; 2021 Apr; 27(2):84-90. PubMed ID: 33162436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient.
    Du JH; Lu J
    J Clin Lab Anal; 2019 Feb; 33(2):e22684. PubMed ID: 30461064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
    Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
    J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort.
    Yuan C; Li N; Mao X; Liu Z; Ou W; Wang SY
    Thorac Cancer; 2017 Jul; 8(4):350-358. PubMed ID: 28544400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-Dependent Changes in Albumin, NLR, PLR, and AFR are Correlated with Shorter Survival in Patients with Gastric Cancer.
    Liu C; Li X
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer.
    Zhang J; Li SQ; Liao ZH; Jiang YH; Chen QG; Huang B; Liu J; Xu YM; Lin J; Ying HQ; Wang XZ
    Oncotarget; 2017 Sep; 8(43):75195-75205. PubMed ID: 29088857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC.
    Ying HQ; Liao YC; Luo YR; Xiong G; Huang Y; Nie RW; Xiong CF; Cheng XX
    Pharmacol Res; 2021 Aug; 170():105734. PubMed ID: 34157424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of the Preoperative Albumin/Fibrinogen Ratio in Patients with Esophageal Squamous Cell Carcinoma after Surgical Resection.
    Zhang H; Ren P; Ma M; Zhu X; Zhu K; Xiao W; Gong L; Tang P; Yu Z
    J Cancer; 2021; 12(16):5025-5034. PubMed ID: 34234871
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II-III colorectal cancer patients.
    Sun F; Peng HX; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Wang XZ; Ying HQ
    Cancer Manag Res; 2018; 10():2151-2161. PubMed ID: 30050325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy.
    Guo D; Li M; Chen D; Jing W; Zhu H; Fu L; Kong L; Yue J; Yu J
    Future Oncol; 2019 Feb; 15(6):625-635. PubMed ID: 30430864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
    Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Combined Detection of Preoperative Albumin-to-Fibrinogen Ratio and Neutrophil-to-Lymphocyte Ratio in Operable Esophageal Squamous Cell Carcinoma Patients without Neoadjuvant Therapy.
    Zheng Z; Lin D; Chen Q; Zheng B; Liang M; Chen C; Zheng W
    Cancer Manag Res; 2021; 13():2359-2370. PubMed ID: 33737833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.